Antibody 2001
Monoclonal antibody therapies
New aspects of autoantibody detection with a new combination of autoantigenic targets
Immune Responses-Regulation of the Immune Response by Antigen
New approaches to dissect degeneracy and specificity in T cell antigen recognition
Structural chemistry and therapeutic intervention of protein-protein interactions
Camel Single-domain Antibodies as Modular Building Units in Bispecific and Bivalent Antibody Constructs
IgA and the IgA Fc receptor
CRITICAL ANALYSIS OF ANTIBODY CATALYSIS
Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates
A novel antibiotic target-drug
the coming of age of radioimmunotherapy
antibodies as next generation therapeutics
Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing
Antibody arrays for high-throughput screening of antibody-antigen interactions
'Anticalins': a new class of engineered ligand-binding proteins with antibody-like properties
Susceptibility of B-cell lymphoma to human antibodies encoded by the V4-34 gene
ANTIBODY ENGINEERING
IGG FC RECEPTORS
A Touch of Antibody Class
Immunomodulatory therapy of human type 1 diabetes
Complex layers of genetic alteration in the generation of antibody diversity
In vivo activity in a catalytic antibody-prodrug system
Generation of Sequence-specific, High Affinity Anti-DNA Antibodies
High-throughput generation and engineering of recombinant human antibodies
Biotechnological applications of phage and cell display
Cosmix-plexing- a novel recombinatorial approach for evolutionary selection from combinatorial libraries
Immune Responses-rrested Differentiation, the Self-Renewing Memory Lymphocyte, and Vaccination
'Immune Responses-Breeding' Antigens for New Vaccines
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Single domain camel antibodies- current status
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries
A PHAGE DISPLAY APPROACH FOR RABBIT ANTIBODY HUMANIZATION
SPECIFICITY AND DEGENERACY IN ANTIGEN RECOGNITION
DNA Vaccines-Aunology, Application, and Optimization
Recognition of antigens by single-domain antibody fragments
IL-10 and its homologs- important immune mediators and emerging immunotherapeutic agents
Regulation of Antibody Responses via Antibodies, Complement, and Fc Receptors
Immunomodulators and delivery systems for vaccination by mucosal routes
Estrogen receptor antibodies
Immune Responses-Immune Control, Memory, and Vaccines
A human myeloma cell line suitable for the generation of human monoclonal antibodies
Antibacterial vaccine design using genomics and proteomics
Antigen Specificity and High Affinity Binding Provided by One Single Loop of a Camel Single-domain Antibody
Cancer vaccines based on dendritic cells loaded with tumor-associated antigens
Antibody-Ccytokine fusion proteins for the therapy of cancer
Creating therapeutic cancer vaccines
Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy
IgA antibodies for cancer therapy
Design and application of diabodies, triabodies and tetrabodies for cancer targeting
Vaccines in urologic malignancies
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
Immune-Boosting Drug Could Help Cancer Patients
Immunotherapy for colorectal cancer
Antibody therapy for residual disease in acute myelogenous leukemia
Ribosome display and affinity maturation- from antibodies to single V-domains and cancer therapeutics
Trastuzumab, Monoclonal Antibody for the Treatment of Breast Cancer -drug
The Emerging Role Of Radioimmunotherapy In Haematological Malignancies
Strategies for cancer therapy using carcinoembryonic antigen vaccines
Clinical approaches to vaccination in oncology
The promise of monoclonal antibodies for the therapy of cancer
Tumour vaccines- a new immunotherapeutic approach in oncology
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine
Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4
Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients
Challenges in the Development of an Effective HIV Vaccine
Hepatitis B vaccines
Epitopes Involved in Antibody-Mediated Protection from Ebola Virus
ADVANCES IN THE TREATMENT OF LUPUS NEPHRITIS
TB vaccines- progress and problems
RNA Editing AIDs Antibody Diversification
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA-MVA Vaccine
AIDS Vaccines Show Promise After Years of Frustration
Protection of a pathogenic HIV-1-SIV chimeric virus by passive infusion of neutralizing antibodies
Helicobacter pylori vaccines-the current status
Progress in vaccination against Helicobacter pylori
Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab
ANTIBODY-TARGETED IMMUNOTHERAPY FOR TREATMENT OF MALIGNANCY
ANTI-TNF THERAPY OF RHEUMATOID ARTHRITIS
Monoclonal antibody therapy for Crohn-rsquos disease
Monoclonal antibody strategies to block angiogenesis
Recent advances in antigen-targeted therapy in non-Hodgkin's lymphoma
Principles and practice of antibiotic therapy of diabetic foot infections
the clinical role of anti-TNFa antibody treatment in Crohn's disease
Antibodies with infinite affinity
Contribution of Receptor Editing to the Antibody Repertoire
Antinuclear antibodies (ANA) Diagnostic value of different methods for screening and differentiation
Targeting of Functional Antibody-Decay-accelerating Factor Fusion Proteins to a Cell Surface
更新于2001-08-08
